TNFi (Tumor Necrosis Factor inhibitor) medication clinical trials

Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

This study is for children aged 2-17 with a type of arthritis called JIA, who haven't fully responded to their first TNF inhibitor medicine. It compares different existing medicines to find the best next steps for treatment.